163.2 ð åèç
163.2.0.1 å¿ è â H. influenzae éå¥
| Type | èšåº |
|---|---|
| Hib (type b) | Pre-vaccine: å ç«¥ meningitis #1, epiglottitis, cellulitis; post-vaccine çœèŠ |
| NTHi | AOM, sinusitis, COPD exacerbation #1, CAP elderly |
| H. parainfluenzae | HACEK IE |
| H. ducreyi | Chancroid (ç ulcer + LAP) |
163.2.0.2 å¿ è â Hib Vaccine
- Conjugate, 2/4/6/12-15 mo
- 1990s onwards 99% reduction
- é« risk: ç¡èŸ, HIV, transplant, antibody def â è£çš® if not received
163.2.0.3 å¿ è â Epiglottitis
- Cherry red epiglottis, drooling, tripod position, voice change
- Donât examine pharynx (airway spasm)
- Lateral neck X-ray: âthumbprint signâ
- Treatment: airway management (intubate / trach) + ceftriaxone IV
- Pre-vaccine era â now mostly adult (GAS, Strep, S. aureus instead)
163.2.0.4 å¿ è â Moraxella catarrhalis
- AOM, sinusitis, COPD exacerbation
- 100% β-lactamase positive â amox-clav
- éå¥ Neisseria: DNase + + å®€å § cold growth +